Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics Analysis as Hub Genes Involved in Gastric Cancer Progression and Prognosis
Open accessThe DOI matches its Crossref record; 72 of the 76 references it cites were found in a registry or an index.
Abstract
Gastric cancer has remained in the top five cancers for over ten years, both in terms of incidence and mortality due to the shortage of biomarkers for disease follow-up and effective therapies. Aiming to fill this gap, we performed a bioinformatics assessment on our data and two additional GEO microarray profiles, followed by a deep analysis of the 40 differentially expressed genes identified. PPI network analysis and MCODE plug-in pointed out nine upregulated hub genes coding for proteins from the collagen family (COL12A1, COL5A2, and COL10A1) or involved in the assembly (BGN) or degradation of collagens (CTHRC1), and also associated with cell adhesion (THBS2 and SPP1) and extracellular matrix degradation (FAP, SULF1). Those genes were highly upregulated at the mRNA and protein level, the increase being correlated with pathological T stages. The high expression of BGN (p = 8 × 10−12), THBS2 (p = 1.2 × 10−6), CTHRC1 (p = 1.1 × 10−4), SULF1 (p = 3.8 × 10−4), COL5A1 (p = 1.3 × 10−4), COL10A1 (p = 5.7 × 10−4), COL12A1 (p = 2 × 10−3) correlated with poor overall survival and an immune infiltrate based especially on immunosuppressive M2 macrophages (p-value range 4.82 × 10−7–1.63 × 10−13). Our results emphasize that these genes could be candidate biomarkers for GC progression and prognosis and new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ao, R., Guan, L., Wang, Y., & Wang, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26524 · Cited by 151 · cited 1×
“An increased expression of THBS2 seems to sustain cancer progression in GC [47] and is associated with a poor prognosis in colorectal cancer [48].”
BackgroundRetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“According to GLOBOCAN 2020’s latest data, gastric cancer (GC) is the fifth most common cancer worldwide, with over 1,000,000 new cases each year, and also the fourth cause of cancer-related death in the world, with a 5-year survival rate of around 32% [1].”
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 1×
“Then, Cytotype Molecular Complex Detection (MCODE) plug-in in Cytoscape software was used to detect hub genes in the PPI network [22].”
MethodSzklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108 · cited 1×
“2021) [20] and Kyoto Encyclopedia of Gene and Genome (KEGG).”
BackgroundNCBI GEO: archive for functional genomics data sets—update
Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1193 · Cited by 10,418 · cited 1×
“gov/geo/; access date 5 November 2021) [17], GSE13911 [18], and GSE79973 [19], including a total of 55 gastric tumor samples and 53 adjacent non-tumor tissues, were used for differential analysis.”
MethodTIMER2.0 for analysis of tumor-infiltrating immune cells
Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa407 · Cited by 5,209
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334 · cited 1×
“Collagen family proteins, together with elastins, fibronectins, and laminins, play an important role in tissue organization as parts of the ECM, sustaining tissue resistance and its main form [27].”
BackgroundThe Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
(2011) · Hepatogastroenterology · doi:10.5754/hge11753 · Cited by 2,435
Cited by
Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer
Necula, L. G., Matei, L., Dragu, D., Pitica, I. M., Neagu, A. I., Bleoţu, C., Diaconu, C. C., & Chivu‐Economescu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012415 · Cited by 98
Self-citationMatsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“[19] Abbreviations: GC, gastric cancer; TCGA, The Cancer Genome Atlas; GEO, Gene Expression Omnibus; GO, gene oncology; KEGG, The Kyoto Encyclopedia of Genes and Genomes; WGCNA, weighted correlation network analysis; TIMER, Tumor Immune Estimation Resource; PPI, protein–protein interaction; N.A.,…”
BackgroundXie, W., Cheng, J. R., Hong, Z., Cai, W., Zhuo, H., Hou, J., Lin, L., Wei, X., Wang, K., Chen, X., et al. (2022) · Cancers · doi:10.3390/cancers15010164 · Cited by 55
“Regarding GC, however, the prognostic value of SPP1 remains controversial [15,16].”
BackgroundHong, J., Du, K., Jin, H., Chen, Y., Jiang, Y., Zhang, W., Chen, D., Zheng, S., & Cao, L. (2024) · Environment International · doi:10.1016/j.envint.2024.108582 · Cited by 47
The Multifaced Role of Collagen in Cancer Development and Progression
Buglio, G. L., Cicero, A. L., Campora, S., & Ghersi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413523 · Cited by 42
Yao, W., Yao, Y., He, W., Zhao, C., Liu, D., Wang, G., & Wang, Z. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.919 · Cited by 16
“Collagen type XII alpha 1 chain (COL12A1), encoded by chromosome 6q12‐q13, is a typical collagen‐building molecule involved in collagen cross‐linking in the tumor microenvironment.(17) At present, the significant role of COL12A1 in multiple cancers is a matter of great concern.”
BackgroundWei, Y., Geng, S., Si, Y., Yang, Y., Chen, Q., Huang, S., Chen, X., Xu, W., Liu, Y., & Jiang, J. (2023) · Advanced Science · doi:10.1002/advs.202306715 · Cited by 19
Feng, X., Liu, H., Sheng, Y., Li, J., Guo, J., Song, W., Li, S., Liu, Z., Zhou, H., Wu, N., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117975 · Cited by 16
Han, M. (2024) · American Journal of Cancer Research · doi:10.62347/rxve7097 · Cited by 13
Chen, M., Liu, H., Hong, B., Xiao, Y., & Qian, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400578r · Cited by 13
“36,37 Therefore, MIF acts as a critical link between TNBC cells and macrophages, potentially driving tumor progression.”
BackgroundTang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Clinical Epigenetics · doi:10.1186/s13148-022-01413-5 · Cited by 12
Liu, B., Li, Y., Xu, Y., Xue, W., & Jin, Z. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00799-5 · Cited by 11
“Mihaela Chivu-Economescu et al. determined that COL12A1 was highly upregulated at the mRNA and protein levels and that the high expression of COL12A1 was correlated with poor overall survival in GC patients [82].”
BackgroundThe role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression
Singh, C. K., Fernandez, S., Chhabra, G., Zaemisch, G. R., Nihal, A., Swanlund, J., Ansari, N., Said, Z., Chang, H., & Ahmad, N. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2349686 · Cited by 10
Li, X., Yin, X., Mi, L., Li, N., Li, S., & Yin, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33795 · Cited by 6
“It was demonstrated that CTHRC1 could contribute to tumor invasion and metastasis by inhibiting tumor cell apoptosis [20].”
BackgroundCen, S., Jiang, D., Lv, D., Xu, R., Hou, J., Yang, Z., Wu, P., Xiong, X., & Gao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1090277 · Cited by 7
“Frontiers in Endocrinology 10 oxidative stress-induced apoptosis, and may also serve as a potential biomarker for gastric cancer progression and prognosis (34, 35).”
BackgroundYuan, H., Pu, X.-F., Wu, H., & Wu, C. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i7.1182 · Cited by 5
Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer
Wang, S., Yang, X., Liu, C., Hu, J., Yan, M., Ding, C., & Fu, Y. (2023) · Medicine · doi:10.1097/md.0000000000035111 · Cited by 5
“[35,36] The results of all these 4 genes were in line with our bioinformatics prediction and clinical sample test, suggesting that COL3A1, COL4A1, COL5A2 and COL12A1 may play a key role in the evolution of GC. 39] In contrast to Jianguo Feng who considered it as antitumor factor to resist…”
Yan, Y., Li, Y.-B., Liang, H., Chen, D., Li, B., & Murshed, A. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010332329241119104430 · Cited by 7
An, Y., Liu, X., Liu, J., Wang, D., Yan, W., Hu, G., Xu, L., & Li, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-05105-x · Cited by 3
“Both COL5A2 and COL12A1, members of the collagen family, have been associated with the progression of gastric cancer 30 .”
Multidimensional effects of genetic mechanisms in cancer occurrence, development and treatment
Wang, X., Shi, X., Liao, S., Su, T., Gu, Y., Zhang, H., & Li, Z. (2026) · Cancer Genetics · doi:10.1016/j.cancergen.2026.03.006 · Cited by 3
Satala, C.-B., Gurau, A.-M., Mihalache, D., Patrichi, G., Mehedinti, R.-C., Leibovici, A. R., & Gurău, G. (2026) · Cells · doi:10.3390/cells15121055 · Cited by 3
“Fibroblast-derived matrix programs, together with macrophage-associated remodeling, may generate microregions that favor invasion and immune protection, particularly at invasive fronts and serosa-adjacent regions [49,50].”
Han, J., Shin, Y., Kim, E., Park, H., & Kim, J. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c01109 · Cited by 3
Shen, F., Liu, X., Ding, F., Yu, Z., Shi, X., Cheng, L., Zhang, X., Jing, C., Zhao, Z., Cao, H., et al. (2025) · Hereditas · doi:10.1186/s41065-025-00398-4 · Cited by 3
“COL3A1, COL4A1, and COL5A2 are involved in extracellular matrix (ECM) remodeling and tissue fibrosis [21, 22], processes crucial for ESCA progression and metastasis, which may enhance their role as more disease-specific markers.”
RetractedNecula, L. G., Dragu, L. D., Matei, L., Pitica, I. M., Dima, S., Bleoţu, C., Diaconu, C. C., & Chivu‐Economescu, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211043 · Cited by 2
“Our previous studies showed that the collagen family and other proteins associated with the assembly mechanism of collagen fibers and with their degradation play an important role during the carcinogenesis process, and could be important biomarkers that predict poor prognosis in GC [6].”
Self-citationThe Diagnostic and Prognostic Value of the Immune Checkpoint BGN in Thymoma
Liu, Y., Chen, S. X., Wang, Y., Zhang, Z., Wang, Z., Tao, Z., Wang, J., & Zhang, P. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10523-5 · Cited by 2
“Furthermore, BGN upregulation in gastric cancer is closely associated with immunosuppressive M2 macrophages (Chivu-Economescu et al. 2022).”
Tseng, K.-Y., Tzeng, Z., Cheng, T.-J. R., Liang, P., & Hung, S. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.947475 · Cited by 1
“carcinoma, lung adenocarcinoma, and osteoarthritis (OA) (Lai et al., 2003; Viviano et al., 2004; Otsuki et al., 2008; Otsuki et al., 2010; Rosen and Lemjabbar-Alaoui, 2010; Hur et al., 2012; Chanalaris et al., 2019; Lin et al., 2020; Severmann et al., 2020; Shamdani et al., 2020; Chivu-Economescu et al., 2022).”
Liang, Y., Lai, Y., Yuan, Y., Yuan, W., Zhang, X., Zhang, B., & Lu, Z. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.03.23 · Cited by 1
Liu, J., Yuan, Q., Cai, R., Zhao, J., Chen, J., Zhang, M., Wang, Y., Zhuang, M., Xu, T., Song, X., et al. (2024) · Current Bioinformatics · doi:10.2174/0115748936346422240930081839 · Cited by 1
[Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma].
Wang, J., Lu, L., He, X., Ma, L., Chen, T., Li, G., & Yu, H. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.101.25
“…IPF 具 有较好的诊断价值。在肿瘤方面,早期的研究 [34] 观察到 各种癌细胞系中 SULF1 转录本普遍低表达,因此认为其 在如卵巢癌、乳腺癌和肝癌等的肿瘤中具有抑癌功能。 然后,后来的研究 [35] 在多种肿瘤组织中均证实了 SULF1 表达的增加。在膀胱上皮癌中,高 SULF1 表达与更高的原 发肿瘤状态与组织学分级以及更差的生存结果相关 [36] 。 同样地,在胃癌中高 SULF1 表达与更差的 OS 和免疫抑制 性的 M2 巨噬细胞浸润相关 [37] 。此外,近期的转基因小鼠 和体外实验 [38] 的重要因素 [39] 。一项研究 [40] 发现敲减 SULF1 不仅抑制了”
Zhao, Y., Liang, Y., Cai, L., Cai, L., Huang, B., Han, P., Zhang, X., Zhang, H., Chen, Z., Yin, X., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100848
Zhang, G., Wang, N., Ma, S., Zhang, Y., Tao, P., & Cai, H. (2025) · Analytical Cellular Pathology · doi:10.1155/ancp/5106674
“Previous reports have shown that fi ve of these genes (BGN [26, 27], UBE2C [28, 29], SPP1 [30, 31], THBS2 [32, 33], and COL1A1 [34, 35]) are associated with the pathogenesis of COVID-19 pneumonia and GC.”
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614481
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614487
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614478
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614469
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614466
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614460
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614484
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614475
Tang, Z., Yang, Y., Zhang, Q., & Liang, T. (2023) · Figshare · doi:10.6084/m9.figshare.22614472
Akbarin, M. M., Farjami, Z., & Álvarez, H. R. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02041-5
COL10A1 at the crossroads of tumor signaling networks and environment remodeling
Wei, E., Guo, X., Wang, K., Gu, W., Zhang, Y., Xianli, W., & Sun, C. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156704
Metadata
- Authors
- Chivu-Economescu, M., Necula, L. G., Matei, L., Dragu, D., Bleotu, C., Sorop, A., Herlea, V., Dima, S., Popescu, I., & Diaconu, C. C.
- Affiliations
- Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, Romania
- Titu Maiorescu University (RO)
- Romanian Academy (RO)
- Institutul Clinic Fundeni (RO)
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-16
- Volume
- 23
- Issue
- 6
- Pages
- 3214
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8950589
- OpenAlex
- W4221033296
- Cited by
- 42
- References
- 76
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 11 · 2023: 18 · 2022: 3
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii (PN-III-P4-ID-PCCF-2016-0158, PN-III-P1-1.1-TE-2019-1864)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- gastric cancer, hub genes, extracellular matrix remodeling, COL12A1, COL5A2, COL10A1, BGN, CTHRC1, thrombospondin-2, osteopontin, SULF1, FAP, M2 macrophages, tumor immune infiltration, prognostic factors, tumor progression, T stage, overall survival
- MeSH terms
- Collagen, Humans, RNA, Messenger, Stomach Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Extracellular Matrix Proteins, Computational Biology, Gene Expression Profiling, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.